Kendall Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Buy |
3,655
+75
| +2% | +$5.78K | 0.05% | 201 |
|
|
2025
Q4 | $284K | Hold |
3,580
| – | – | 0.06% | 196 |
|
|
2025
Q3 | $270K | Hold |
3,580
| – | – | 0.06% | 206 |
|
|
2025
Q2 | $247K | Hold |
3,580
| – | – | 0.07% | 200 |
|
|
2025
Q1 | $243K | Sell |
3,580
-1,100
| -24% | -$65.8K | 0.07% | 197 |
|
|
2024
Q4 | $210K | Sell |
4,680
-5,163
| -52% | -$290K | 0.06% | 206 |
|
|
2024
Q3 | $619K | Sell |
9,843
-2,247
| -19% | -$131K | 0.19% | 134 |
|
|
2024
Q2 | $714K | Buy |
12,090
+11
| +0.1% | +$688 | 0.24% | 114 |
|
|
2024
Q1 | $963K | Sell |
12,079
-471
| -4% | -$36K | 0.33% | 89 |
|
|
2023
Q4 | $991K | Sell |
12,550
-395
| -3% | -$28.1K | 0.38% | 82 |
|
|
2023
Q3 | $904K | Sell |
12,945
-100
| -0.8% | -$7.09K | 0.4% | 78 |
|
|
2023
Q2 | $902K | Sell |
13,045
-554
| -4% | -$39.4K | 0.4% | 82 |
|
|
2023
Q1 | $1.01M | Buy |
13,599
+24
| +0.2% | +$2.01K | 0.49% | 65 |
|
|
2022
Q4 | $1.26M | Sell |
13,575
-25
| -0.2% | -$2.41K | 0.64% | 49 |
|
|
2022
Q3 | $1.3M | Buy |
13,600
+98
| +0.7% | +$9.7K | 0.75% | 40 |
|
|
2022
Q2 | $1.25M | Sell |
13,502
-460
| -3% | -$44.9K | 0.69% | 44 |
|
|
2022
Q1 | $1.41M | Sell |
13,962
-15
| -0.1% | -$1.58K | 0.68% | 42 |
|
|
2021
Q4 | $1.44M | Buy |
13,977
+125
| +0.9% | +$11.6K | 0.68% | 42 |
|
|
2021
Q3 | $1.18M | Buy |
13,852
+495
| +4% | +$41.5K | 0.64% | 55 |
|
|
2021
Q2 | $1.11M | Buy |
13,357
+432
| +3% | +$35.4K | 0.63% | 51 |
|
|
2021
Q1 | $972K | Buy |
12,925
+15
| +0.1% | +$1.09K | 0.6% | 55 |
|
|
2020
Q4 | $882K | Buy |
12,910
+270
| +2% | +$17.6K | 0.64% | 51 |
|
|
2020
Q3 | $738K | Sell |
12,640
-570
| -4% | -$35.5K | 0.64% | 55 |
|
|
2020
Q2 | $858K | Buy |
13,210
+405
| +3% | +$25.5K | 0.82% | 47 |
|
|
2020
Q1 | $760K | Sell |
12,805
-2,265
| -15% | -$151K | 0.86% | 46 |
|
|
2019
Q4 | $1.12M | Sell |
15,070
-1,620
| -10% | -$114K | 0.88% | 44 |
|
|
2019
Q3 | $1.05M | Sell |
16,690
-3,180
| -16% | -$188K | 0.93% | 39 |
|
|
2019
Q2 | $1.08M | Sell |
19,870
-6,300
| -24% | -$339K | 0.98% | 37 |
|
|
2019
Q1 | $1.41M | Sell |
26,170
-190
| -0.7% | -$11.7K | 1.34% | 22 |
|
|
2018
Q4 | $1.73M | Buy |
26,360
+753
| +3% | +$56.2K | 1.79% | 11 |
|
|
2018
Q3 | $2.02M | Buy |
25,607
+1,682
| +7% | +$120K | 1.72% | 12 |
|
|
2018
Q2 | $1.54M | Buy |
23,925
+1,335
| +6% | +$88K | 1.36% | 17 |
|
|
2018
Q1 | $1.41M | Buy |
22,590
+2,040
| +10% | +$146K | 1.22% | 20 |
|
|
2017
Q4 | $1.49M | Buy |
+20,550
| New | +$1.49M | 1.32% | 18 |
|
Other funds holding CVS
VCM
VPM
Kendall Capital Management's CVS Position: Q1 2026 in Review
Kendall Capital Management increased its CVS Health (CVS) stake by 2.1% in Q1 2026, buying an estimated $5.78K and bringing the position to 3,655 shares worth $263K. The position accounts for 0.05% of the portfolio, ranked #201.
Kendall Capital Management first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.02M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Kendall Capital Management held 3,655 shares of CVS Health worth $263K as of Q1 2026.
- Kendall Capital Management bought 75 CVS Health shares in Q1 2026, an estimated $5.78K.
- CVS Health made up 0.05% of Kendall Capital Management's portfolio in Q1 2026, its #201 holding.
- Kendall Capital Management first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
- Kendall Capital Management's CVS Health position peaked at $2.02M in Q3 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.